New drug trial targets multiple advanced cancers with common genetic marker

NCT ID NCT06695845

Recruiting now Disease control Sponsor: Jazz Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental drug called zanidatamab for people with advanced cancers that have a specific genetic marker called HER2. The trial will enroll about 200 adults whose cancers have progressed after at least one prior treatment. Researchers want to see if the drug can shrink tumors and how long the effects last, while carefully monitoring side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Affiliated Oncologists
RECRUITING

Chicago Ridge, Illinois, 60415, United States
Alliance Cancer Specialists
RECRUITING

Horsham, Pennsylvania, 19044, United States
Arizona Oncology Associates, PC - NAHOA
RECRUITING

Prescott, Arizona, 86301, United States
Asan Medical Center
RECRUITING

Seoul, 05505, South Korea
Barbara Ann Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States
Blue Ridge Cancer Care
RECRUITING

Roanoke, Virginia, 24014, United States
Florida Cancer Specialists - East
RECRUITING

West Palm Beach, Florida, 33401, United States
Florida Cancer Specialists - Lake Nona
RECRUITING

Orlando, Florida, 32827, United States
Florida Cancer Specialists - North
RECRUITING

St. Petersburg, Florida, 33705, United States
Florida Cancer Specialists - South
RECRUITING

Fort Myers, Florida, 33901, United States
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Rocky Mountain Cancer Center
RECRUITING

Littleton, Colorado, 80120, United States
SCRI Oncology Partners
RECRUITING

Nashville, Tennessee, 37203, United States
Samsung Medical Center
RECRUITING

Gangnam-gu, Seoul, 06351, South Korea
Seoul National University Bundang Hospital
RECRUITING

Seoul, 13620, South Korea
Seoul National University Hospital
RECRUITING

Jongno-gu, Seoul, 03080, South Korea
Severance Hospital
RECRUITING

Seodaemun-gu, Seoul, 03722, South Korea
Tennessee Cancer Specialists
RECRUITING

Knoxville, Tennessee, 37909, United States
Texas Oncology - DFW
RECRUITING

Dallas, Texas, 75246, United States
Texas Oncology - San Antonio
RECRUITING

San Antonio, Texas, 78217, United States
Texas Oncology - West Texas
RECRUITING

Amarillo, Texas, 79124, United States

Conditions

Explore the condition pages connected to this study.

BREAST CANCER COLORECTAL CANCER ENDOMETRIAL CANCER ESOPHAGEAL CANCER GASTRIC CANCER GASTROESOPHAGEAL CANCER HER-2 PROTEIN OVEREXPRESSION NON-SMALL CELL LUNG CANCER OVARIAN CANCER PANCREATIC CANCER SALIVARY GLAND CANCER UROTHELIAL CARCINOMA